Characteristics of autochthonous hepatitis e virus infection in solid-organ transplant recipients in France

Journal of Infectious Diseases

Volumn 202, Issue 6, 2010, Pages 835-844

  Legrand Abravanel, Florence ^a,b   Kamar, Nassim ^c   Sandres Saune, Karine ^a,b   Garrouste, Cyril ^a,b,c   Dubois, Martine ^a,b   Mansuy, Jean Michel ^b   Muscari, Fabrice ^c   Sallusto, Federico ^c   Rostaing, Lionel ^a,c   Izopet, Jacques ^a,b  

^a INSERM   (France)

^b CHU PURPAN   (France)

^c CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCINEURIN INHIBITOR; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MYCOPHENOLIC ACID; STEROID; VIRUS RNA;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; FRANCE; GENOTYPE; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MEAT; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY;

ADULT; AGED; ANIMALS; BIRDS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEEDING BEHAVIOR; FEMALE; FRANCE; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MEAT; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RISK FACTORS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SWINE; TRANSPLANTS;

EID: 77955962476     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655899     Document Type: Article

References (48)

1. Emerson SU, Purcell RH. Hepatitis E virus. Rev Med Virol 2003; 13: 145-154 .
2. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8:698-709 .
3. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48:494-503 .
4. Dalton HR, Thurairajah PH, Fellows HJ, et al. Autochthonous hepatitis E in southwest England. J Viral Hepat 2007; 14:304-309 .
5. Legrand-Abravanel F, Mansuy JM, Dubois M, et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 2009; 15:110-114 .
6. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16:5-36 .
7. Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 1997; 94:9860-9865 .
8. Christensen PB, Engle RE, Hjort C, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008; 47:1026-1031 .
9. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J ClinMicrobiol 2002; 40:117-122 .
10. Renou C, Cadranel JF, Bourliere M, et al. Possible zoonotic transmission of hepatitis E from pet pig to its owner. Emerg Infect Dis 2007; 13:1094-1096 .
11. Li TC, Chijiwa K, Sera N, et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 2005; 11:1958-1960 .
12. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362:371-373 .
13. Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003; 9:448-454 .
14. Rutjes SA, Lodder WJ, Lodder-Verschoor F, et al. Sources of hepatitis E virus genotype 3 in the Netherlands. Emerg Infect Dis 2009; 15:381-387 .
15. Peron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007; 14:298-303 .
16. Gerolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50:622-624 .
17. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14: 547-553 .
18. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl JMed 2008; 358:811-817 .
19. Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150:430-431 .
20. Mansuy JM, Huynh A, Abravanel F, Recher C, Peron JM, Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis 2009; 48:373-374 .
21. le Coutre P, Meisel H, Hofmann J, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58:699-702 .
22. Peron JM, Mansuy JM, Recher C, et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006; 21:1223-1224 .
23. Colson P, Kaba M, Moreau J, Brouqui P. Hepatitis E in an HIV-infected patient. J Clin Virol 2009; 45:269-271 .
24. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025-1027 .
25. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358:859-860 .
26. Kamar N, Mansuy JM, Cointault O, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8:1744-1748 .
27. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 2008; 80:95-101 .
28. Legrand-Abravanel F, Thevenet I, Mansuy JM, et al. Good performance of immunoglobulin Massays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009; 16:772-774 .
29. Saravanabalaji S, Tripathy AS, Dhoot RR, Chadha MS, Kakrani AL, Arankalle VA. Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis E. Intervirology 2009; 52:78-85 .
30. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-293 .
31. Mansuy JM, Peron JM, Abravanel F, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area .J Med Virol 2004; 74:419-424 .
32. Mansuy JM, Abravanel F, Miedouge M, et al. Acute hepatitis E in south-west France over a 5-year period. J Clin Virol 2009; 44:74-77 .
33. Said B, Ijaz S, Kafatos G, et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009; 15:1738-1744 .
34. Li TC, Miyamura T, Takeda N. Detection of hepatitis E virus RNA from the bivalve Yamato-Shijimi (Corbicula japonica) in Japan. Am J Trop Med Hyg 2007; 76:170-172 .
35. Kaba M, Davoust B, Marie JL, et al. Frequent transmission of hepatitis E virus among piglets in farms in Southern France. J Med Virol 2009;81: 1750-1759 .
36. Mansuy JM, Legrand-Abravanel F, Calot JP, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008; 80:289-293 .
37. Wichmann O, Schimanski S, Koch J, et al. Phylogenetic and casecontrol study on hepatitis E virus infection in Germany. J Infect Dis 2008; 198:1732-1741 .
38. Matsuda H, Okada K, Takahashi K, Mishiro S. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect Dis 2003; 188:944 .
39. Kaba M, Davoust B, Marie JL, Colson P. Detection of hepatitis E virus in wild boar (Sus scrofa) livers. Vet J doi:10.1016/j.tvjl.2009.08.008 .Published 9 September 2009 .
40. Kar P, Jilani N, Husain SA, et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol 2008; 103:2495-2501 .
41. Panda SK, Thakral D, Rehman S. Hepatitis E virus. Rev Med Virol 2007; 17:151-180 .
42. Aragona M, Macagno S, Caredda F, et al. Serological response to the hepatitis delta virus in hepatitis D. Lancet 1987; 1:478-480 .
43. Brillanti S, Masci C, Miglioli M, Barbara L. Serum IgM antibodies to hepatitis C virus in acute and chronic hepatitis C. Arch Virol Suppl 1993; 8:213-218 .
44. Nagayama R, Miyake K, Tsuda F, Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol 1994; 42:311-317 .
45. Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008; 372:321-332 .
46. Kamar N, Rostaing L, Selves J, et al. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005; 5:1704-1712 .
47. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895-903 .
48. Sester M, Gartner BC, Girndt M, Sester U. Vaccination of the solid organ transplant recipient. Transplant Rev (Orlando) 2008; 22:274-284.